You're saying that a device manufacturer, like this Medtronic defibrillator, when it went through the whole premarket approval and everything, and it was approved, later on they made a change to it, but it didn't have to go back and be approved, and they did no human trials?
Harkin questions the approval process for device modifications without human trials.
Share & report
More from Tom Harkin
I thank my dear friend and colleague, long-standing in the Senate and in the House before, and to thank the Senator for her intellectual and energetic leadership on all issues concerning the environment and the health of our people and the…
Mr. President, I ask unanimous consent that Leela Baggett, Vincent Brown, and Naomi Pitkin, interns with the Senate Health, Education, Labor, and Pensions Committee, be granted floor privileges for the remainder of today's session. The…
Mr. President, I wish to announce that the Committee on Health, Education, Labor, and Pensions will to meet on November 20, 2014, at 10 a.m. in room SD-430 of the Dirksen Senate Office Building, to conduct a hearing entitled ``Hearing on…
Mr. President, I am proud to introduce my comprehensive proposal to reauthorize the Higher Education Act, the main law governing institutions of higher education in this country. My bill, the Higher Education Affordability Act, is the…
Other voices in this conversation
